DAVID R. JOY is a partner in Keller and Heckman’s Washington office. He counsels clients in a broad range of food and drug regulatory matters. He began his career on Keller and Heckman’s scientific staff, then worked as a law clerk, Associate, and Partner with the firm before taking a position with the U.S. Food and Drug Administration (FDA) in 2008. David worked for almost 15 years in the Office of Regulatory Policy (ORP) in FDA’s Center for Drug Evaluation and Research, serving as Director of ORP’s Division of Regulatory Policy IV for six years. At FDA, David was involved in a wide variety of regulatory policy matters, including drug approvals and withdrawals of approval, accelerated approval and other expedited programs, drug establishment registration and listing, inactive ingredient review and labeling, drug advertising and promotion, FDA’s post-approval drug safety authorities, the regulation of drug/device combination products, and the drug/device jurisdictional boundary. David authored or helped develop responses to numerous citizen petitions during his time at FDA. In 2014, David served as a senior policy analyst in FDA’s Europe office during a 3-month detail and participated in discussions with the European Medicines Agency on the Mutual Reliance Initiative. In 2023, David re-joined Keller and Heckman, where he advises clients on regulatory matters involving drugs, food additives, dietary supplements, and medical devices, including premarket clearance requirements and advertising and labeling provisions applicable to these products. Additionally, he helps clients navigate the Generally Recognized as Safe (GRAS) determination process and provides advice on the regulation of antimicrobials used in food and non-food applications. David holds a B.S. in Chemistry from the University of Maryland and a law degree from George Washington University.